About US
Contact us
-
Cassiopea scores FDA approval for Winlevi, the first novel acne med in decadesIt’s been decades since a novel acne treatment hit the scene,but that’s set to change with Cassiopea’s approval forWinlevi. The FDA onThursdayapprovedthe new prescription acne medication, set for use2020/8/27
-
FDA puts India's Wintac on blast for lackadaisical probe into bacterial contaminationWhen FDA investigators identify potentially grave issues at a drug manufacturer's facility, the general assumption is that the company will do its best to remedy the problem. But few things rileup th2020/8/27
-
Teva indicted on U.S. price-fixing charges after walking away from settlement offersWith the walls closing in around it on a yearslong generics price-fixing probe, Israeli drugmaker Teva faced two options: Reach a deal with prosecutors or gamble. Teva chose to roll the dice, and now2020/8/26
-
Upset with Trump's international pricing index, PhRMA submits a counteroffer: PoliticoAfter a harsh initial reaction to President Donald Trump's order tyingU.S. drug prices to the much lower stickers abroad, pharma companies have come to the negotiating table. In a counteroffer sent t2020/8/26
-
Biogen conference likely linked to 'tens of thousands' of COVID-19 cases, researchers sayIt’s been some months since Biogen’s Februarymanagementconference has been in the news,but as the pandemic drags on, researchersare now linking the early “superspreadingevent” withtens of thousands o2020/8/25
-
FDA chief Hahn walks back plasma claims, but his correction still missed the mark, experts sayWith the emergency use authorization (EUA) for convalescent plasma to treat COVID-19, the FDA and Commissioner Stephen Hahn, M.D., touched off a controversy—particularly about his presentation of the2020/8/25
-
AbbVie's Skyrizi stands to gain as docs move away from older psoriasis meds—Amgen's Otezla includedIn an increasingly crowded psoriasis market, a raft of next-gen biologics is looking to topple an older suite of drugs for sales supremacy. Dermatologists seem to be on board with that shift, a good2020/8/24
-
Takeda to offload Japan consumer health unit to Blackstone for $2.3BAfter months of rumors, Takeda has finally unveiled a deal to sell its Japanese consumer health business to Blackstone Group. The U.S. private investment shop couldpayJPY242 billion ($2.3 billion) fo2020/8/24
-
Roche's Polivy gets thumbs-up from England's cost watchdog after earlier rejectionWith its three blockbuster oncology meds under assault from biosimilar rivals, Swiss drugmaker Roche is looking to its next-gen therapies for a boost. New lymphoma launch Polivy faced a setback earli2020/8/21
-
Compounder SCA Pharma recalls heparin products over potentially lethal preservative mix-upSCA Pharma set out to expand capacity for key drugs earlier this summer. Now, thecompounding pharmacy ispullingone of itscritical meds—common blood thinner heparin—from hospitals nationwideover inacc2020/8/21